Predictions of carbamazepine concentrations using a Bayesian program (PKS System, Abbott): A retrospective evaluation in an outpatient population

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 7, 1997, Pages 734-736

  Gaulier, J M ^a,b   Boulieu, R ^a,b   Fischer, C ^b   Mauguiere, F ^b  

^a UNIVERSITÉ LYON 1   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

ACCURACY; ADOLESCENT; ADULT; ANALYTICAL ERROR; ARTICLE; CHILD; CLINICAL ARTICLE; COMPUTER PROGRAM; DOSE CALCULATION; DRUG BLOOD LEVEL; EPILEPSY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; OUTPATIENT; RETROSPECTIVE STUDY; STEADY STATE;

EID: 0030746590     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06102.x     Document Type: Article

References (11)

1. Bertilsson, L. (1978) Clinical pharmacokinetics of carbamazepine. Clin. Pharmacokinet. 3: 128-143
2. Bertilsson, L., Thomson, T. (1986) Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update. Clin. Pharmacokinet. 11: 177-198
3. Botha, J., Bobat, R. A., Moosa, A., Miller, R. (1990) Therapeutic drug monitoring in a paediatric epilepsy clinic. S. Afr. Med. J. 77: 511-514
4. Bouvet, O., Fabre, D., Alric, R., Cociglio, M., Bressolle, F. (1992) Prevision des taux plasmatiques par estimation bayesienne des paramètres pharmacocinétiques de deux médicaments antiépileptiques: la carbamazépine et l'acide valproique. In: Bres, J., Panis, G. (eds) Pharmacocinétique: de la Recherche à la Clinique. John Libbey Eurotext, Paris, pp 324-329
5. El Battah, A., Belgia, S., Alric, R. (1995) Validation of a quick modelling program generating clearance estimates at steady state for routine therapeutic drug monitoring. Ther. Drug. Monit. 17: 348-355
6. Ertas, M., Tuglular, I., Gokden, O., Onat, E. (1994) OPT computer program package on individual carbamazepine dose optimization: a clinical validity test. Eur. J. Drug. Metab. Pharmacokinet. Special issue: 224-227
7. Garcia, M. J., Alonso, A. C., Maza, A., Santos, D., Matesanz, C., Dominguez-Gil, A. (1988) Comparison of methods of carbamazepine dosage individualization in epileptic patients. J. Clin. Pharmacol. Ther. 13: 375-380
8. Mallet, A., Trouvin, J. H. (1990) Notion de Pharmacocinétique de population. In: Houin, G. (ed.) Pharmacocinétique. Ellipses, Paris, pp 127-144
9. Morselli, P. L., Bossi, L. (1982) Absorption, distribution and excretion. In: Woodbury, D. M., Penry, J. K., Pippenger, C. E. (eds) Anti-epileptic Drugs. Raven Press, New York, pp 465-482
10. Sheiner, L. B., Beal, S. L. (1981) Some suggestions for measuring predictive performance. J. Pharmacokinet. Biopharm. 9: 503-512
11. Thomson, A. H., Whiting, B. (1992) Bayesian parameter estimation and population pharmacokinetics. Clin. Pharmacokinet. 22: 447-467